Publications by authors named "Xiumin Han"

Article Synopsis
  • Human alveolar echinococcosis is a challenging parasitic disease that is hard to treat and often untreated, leading to high healthcare costs.
  • Current treatment relies on albendazole, which isn't fully effective and can have serious side effects, highlighting the need for better options.
  • Pyronaridine, an antimalarial drug, has shown promising results in mouse models for treating the disease, significantly reducing parasite size and counts compared to albendazole, and could serve as an alternative therapy, while another compound, pirenzepine, also shows potential for further research.
View Article and Find Full Text PDF
Article Synopsis
  • - Alveolar echinococcosis (AE) is a serious parasitic disease that mainly impacts the liver and currently has limited treatment options, prompting researchers to explore better drug delivery methods.
  • - In this study, biocompatible PLGA nanoparticles were developed to encapsulate a new anti-AE drug, H1402, demonstrating high encapsulation efficiency and enhanced delivery to liver tissue.
  • - The results showed that H1402-loaded nanoparticles significantly decreased parasite levels in infected mice and had improved therapeutic effects with reduced toxicity compared to free H1402 and traditional treatments like albendazole.
View Article and Find Full Text PDF

Blastocystis is a common human intestinal protozoan parasite. Little is known about its prevalence in echinococcosis. This study tested whether Echinococcus multilocularis infection would increase host susceptibility to Blastocystis.

View Article and Find Full Text PDF

Alveolar echinococcosis (AE) caused by infection with E. multilocularis metacestode, represents one of the most fatal helminthic diseases. AE is principally manifested with infiltrative, proliferating hepatic mass, resembling primary hepatocellular carcinoma.

View Article and Find Full Text PDF

Background: Cystic echinococcosis (CE) is a life-threatening zoonosis caused by the larval form of Echinococcus granulosus tapeworm. Our previous study showed that an approved drug pyronaridine (PND) is highly effective against CE, both in vitro and in an animal model. To identify possible target genes, transcriptome analysis was performed with E.

View Article and Find Full Text PDF

The present study reports a rare case of Taenia saginata infection, which was initially diagnosed as acute cholecystitis in a Tibetan patient at the Qinghai-Tibetan Plateau pastoral area, China. A 45-year-old female was initially diagnosed with acute cholecystitis at a hospital in China. She had a slight fever, weight loss and constipation and complained of pain in the upper abdomen and left back areas.

View Article and Find Full Text PDF

Objectives: Liver echinococcosis is a severe zoonotic disease caused by (tapeworm) infection, which is epidemic in the Qinghai region of China. Here, we aimed to explore biomarkers and establish a predictive model for the diagnosis of liver echinococcosis.

Methods: Microarray profiling followed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis was performed in liver tissue from patients with liver hydatid disease and from healthy controls from the Qinghai region of China.

View Article and Find Full Text PDF

BACKGROUND Use of renin-angiotensin-aldosterone system inhibitors in coronavirus disease 2019 (COVID-19) patients lacks evidence and is still controversial. This study was designed to investigate effects of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) on clinical outcomes of COVID-19 patients and to assess the safety of ACEIs/ARBs medication. MATERIAL AND METHODS COVID-19 patients with hypertension from 2 hospitals in Wuhan, China, from 17 Feb to 18 Mar 2020 were retrospectively screened and grouped according to in-hospital medication.

View Article and Find Full Text PDF

Background: Echinococcosis is a life-threatening parasitic disease caused by Echinococcus spp. tapeworms with over one million people affected globally at any time. The Echinococcus spp.

View Article and Find Full Text PDF

Background: Cystic echinococcosis (CE), a condition caused by the larval stage of the dog tapeworm Echinococcus granulosus sensu stricto, is a globally distributed zoonotic disease. Current treatment options for CE are limited, and an effective and safe anti-echinococcal drug is urgently required.

Methods: Drug repurposing strategy was employed to identify new therapeutic agents against echinococcal cysts.

View Article and Find Full Text PDF

Aim: Istaroxime is a first-in-class agent which acts through inhibition of the sarcolemmal Na /K pump and activation of the SERCA2a pump. This study assessed the effects of a 24 h infusion of istaroxime in patients hospitalised for acute heart failure (AHF).

Methods And Results: We included patients hospitalised for AHF with left ventricular ejection fraction ≤40% and E/e' > 10.

View Article and Find Full Text PDF

Both alveolar echinococcosis (AE) and cystic echinococcosis are endemic in China, among which alveolar echinococcosis has a very high mortality rate. The survey results showed the prevalence and scope of AE in China and identified high-risk groups including children, monks, herdsmen and illiterate people. At the same time, all the cases found in the survey (more than 90% of the patients did not go to the hospital for diagnosis and treatment before survey) were promptly diagnosed and treated.

View Article and Find Full Text PDF

Background: Echinococcoses, caused by metacestodes of Echinococcus granulosus (cystic echinococcosis; CE) and E. multilocularis (alveolar echinococcosis; AE), represent major emerging parasitic diseases. These enzootic helminthiases invoke significant public health concerns and social burdens in endemic areas.

View Article and Find Full Text PDF

This study examined Echinococcus spp. genotypes and genetic variants isolated from humans as well as domestic and wild animals from the Qinghai-Tibetan Plateau Area using the cox1 gene. All samples except the pika isolates were identified as the Echinococcus granulosus sensu stricto.

View Article and Find Full Text PDF

This study was conducted to investigate the efficacy of a new formulation of MBZ oily suspension (MBZ-OS) in experimentally Echinococcus multilocularis-infected mice. MBZ-OS was prepared and administered to mice infected with E. multilocularis at 12.

View Article and Find Full Text PDF

The hepatic echinococcosis is an anthropozoonosis and caused by the larva of . The main pathogenic type of in China is and , which cause cystic echinococcosis and alveolar echinococcosis respectively. At present, the treatment of hepatic echinococcosis has made great progress, but there are still some difficulties in the treatment of complex echinococcosis, especially of the cases existing one or more complications, and the focus of infection encroaching the hepatic portal, important vessels and bile vessel.

View Article and Find Full Text PDF

Objective: To analyze the blood supply and metabolism in the marginal area of foci of hepatic alveolar echinococcosis by quantitative perfusion parameters.

Methods: Thirty patients with hepatic alveolar echinococcosis were scanned with the Revolution CT and the images were analyzed. The perfusion parameters, such as the bloodflow (BF), time to peak (TTP), blood volume (BV), mean transit time (MTT) and hepatic arterial fraction (HAF) were compared among different groups.

View Article and Find Full Text PDF

Objective: To analyze the imaging manifestations of 79 cases of hepatic echinococcosis retrospectively, so as to provide evidences for improving the diagnosis and differential diagnosis of the disease.

Methods: Seventy-nine patients with hepatic echinococcosis who underwent imaging examinations and pathologic confirmation in Qinghai Provincial People's Hospital from 2014 to 2017 were chosen as the investigation objects, and the data of their medical records and imaging manifestations were collected and analyzed.

Results: Among the 79 cases of hepatic echinococcosis, 57 were suffered from cystic echinococcosis (CE) and 22 were suffered from alveolar echinococcosis (AE) .

View Article and Find Full Text PDF

Objective: To evaluate the accuracy of CT imaging of inferior vena cava and hepatic vein in patients with hepatic cystic echinococcosis.

Methods: A total of 100 patients with hepatic cystic echinococcosis were given triple-phase abdominal CT scan, and the reconstructed images of the inferior vena cava and hepatic vein were obtained and compared to the real situation during the surgical operation. The reliability of the CT evaluation of the echinococcus cyst lesion invading inferior vena cava and hepatic vein was analyzed.

View Article and Find Full Text PDF

Objective: To evaluate the value of the three-dimensional visualization technology for the preoperative assessment of liver autotransplantation for end-stage hepatic alveolar echinococcosis.

Methods: A total of 8 patients with end-stage hepatic alveolar echinococcosis undergoing liver autotransplantation in Qinghai Provincial People's Hospital from May 2013 to July 2017 were collected. All cases received preoperative abdominal CT scanning and dynamic three-phase enhanced CT scanning, and the original CT data were transferred to the human 3D visualization virtual surgical planning system.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore the link between gallbladder diseases and hepatic alveolar echinococcosis in children by analyzing clinical data from a hospital over five years.
  • Out of 51 child patients, a significant number had gallbladder-related complications, with 78.43% showing symptoms and 58.82% experiencing complications after surgery.
  • Key factors influencing gallbladder complications included the classification of the disease, liver segment involvement, and characteristics of lesions, highlighting the need for careful monitoring and management in affected patients.
View Article and Find Full Text PDF

Objective: To detect the expression of follicuLar helper T cells (Tfh) and interleukin-21 (IL-21) in the peripheral blood of patients with hepatic echinococcosis and healthy controls, so as to explore the associations of Tfh and IL-21 expression with the progression of hepatic echinococcosis.

Methods: Fifty cases of hepatic echinococcosis and healthy controls were collected from Qinghai Provincial People's Hospital, respectively. Flow cytometry was used to detect the expression of Tfh cells in the peripheral blood of hepatic echinococcosis patients and healthy controls, and enzyme-linked immunosorbent assay (ELISA) was used to detect serum IL-21 expression in hepatic echinococcosis patients and healthy controls.

View Article and Find Full Text PDF

Background: As part of an ongoing program that aims to use early detection and timely treatment to improve the control of echinococcosis, especially in younger age groups, we undertook a series of active surveys among Qinghai-Tibetan children in the Qinghai Province of Northwestern China in 2011 and 2012. The significant outcomes that resulted from this study emphasize the need to draw attention to echinococcosis, both alveolar echinococcosis (AE) and cystic echinococcosis (CE), so that policy development is promoted and suitable avenues for control are identified in the highly endemic areas on the Tibetan Plateau.

Methods: A total of 19 629 primary school students, aged 6-18 years, with a dominant Tibetan background underwent abdominal ultrasound examination, and 86.

View Article and Find Full Text PDF

Background: Echinococcus multilocularis causes alveolar echinococcosis (AE) and is widely prevalent in Qinghai Province, China, where a number of different species have been identified as hosts. However, limited information is available on the Qinghai vole (Lasiopodomys fuscus), which is hyper endemic to Qinghai Province and may represent a potential intermediate host of E. multilocularis.

View Article and Find Full Text PDF
Article Synopsis
  • * There are various surgical approaches available, each with specific indications and associated risks, which influence treatment decisions.
  • * The paper discusses these surgical methods and their applications in clinical practice to aid in making informed choices for treatment.
View Article and Find Full Text PDF